Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma

NARecruitingINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Signet Ring Cell Gastric Adenocarcinoma
Interventions
PROCEDURE

peri-operative chemotherapy

Usual treatment strategy for gastric adenocarcinoma

PROCEDURE

Surgery first

strategy with a surgical procedure first, without the usual peri-operative chemotherapy

Trial Locations (1)

59037

RECRUITING

General and digestive surgical department, Claude Huriez Hospital, University Hospital, Lille

All Listed Sponsors
collaborator

Federation Francophone de Cancerologie Digestive

OTHER

collaborator

UNICANCER

OTHER

collaborator

Federation of Research in Surgery (FRENCH)

OTHER

lead

University Hospital, Lille

OTHER

NCT01717924 - Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma | Biotech Hunter | Biotech Hunter